BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37899386)

  • 1. Transplant Vasculopathy Versus Native Atherosclerosis: Similarities and Differences.
    Weis M; Weis M
    Transplantation; 2024 Jun; 108(6):1342-1349. PubMed ID: 37899386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optical coherence tomography for characterization of cardiac allograft vasculopathy in late survivors of pediatric heart transplantation.
    Tomai F; De Luca L; Petrolini A; Di Vito L; Ghini AS; Corvo P; De Persio G; Parisi F; Pongiglione G; Giulia Gagliardi M; Prati F
    J Heart Lung Transplant; 2016 Jan; 35(1):74-79. PubMed ID: 26452998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac allograft vasculopathy: a donor or recipient induced pathology?
    van den Hoogen P; Huibers MM; Sluijter JP; de Weger RA
    J Cardiovasc Transl Res; 2015 Mar; 8(2):106-16. PubMed ID: 25652948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Layered Fibrotic Plaques Are the Predominant Component in Cardiac Allograft Vasculopathy: Systematic Findings and Risk Stratification by OCT.
    Clemmensen TS; Holm NR; Eiskjær H; Løgstrup BB; Christiansen EH; Dijkstra J; Barkholt TØ; Terkelsen CJ; Maeng M; Poulsen SH
    JACC Cardiovasc Imaging; 2017 Jul; 10(7):773-784. PubMed ID: 28330670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac allograft vasculopathy: Insights on pathogenesis and therapy.
    Lee F; Nair V; Chih S
    Clin Transplant; 2020 Mar; 34(3):e13794. PubMed ID: 31991002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epicardial fat volume is related to the degree of cardiac allograft vasculopathy.
    Roest S; Budde RPJ; Brugts JJ; von der Thüsen J; van Walsum T; Taverne YJHJ; Zijlstra F; Bos D; Manintveld OC
    Eur Radiol; 2023 Jan; 33(1):330-338. PubMed ID: 35986769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuated-Signal Plaque Progression Predicts Long-Term Mortality After Heart Transplantation: IVUS Assessment of Cardiac Allograft Vasculopathy.
    Okada K; Fearon WF; Luikart H; Kitahara H; Otagiri K; Tanaka S; Kimura T; Yock PG; Fitzgerald PJ; Yeung AC; Valantine HA; Khush KK; Honda Y
    J Am Coll Cardiol; 2016 Jul; 68(4):382-92. PubMed ID: 27443435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diverse morphologic manifestations of cardiac allograft vasculopathy: a pathologic study of 64 allograft hearts.
    Lu WH; Palatnik K; Fishbein GA; Lai C; Levi DS; Perens G; Alejos J; Kobashigawa J; Fishbein MC
    J Heart Lung Transplant; 2011 Sep; 30(9):1044-50. PubMed ID: 21640617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac allograft vasculopathy: real or a normal morphologic variant?
    Houser S; Muniappan A; Allan J; Sachs D; Madsen J
    J Heart Lung Transplant; 2007 Feb; 26(2):167-73. PubMed ID: 17258151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Quantitative Flow Ratio in Predicting Future Cardiac Allograft Vasculopathy in Heart Transplant Recipients.
    Spitaleri G; Brugaletta S; Potena L; Mirabet S; González-Costello J; Zucchetti O; Masetti M; Asmarats L; Gual M; Nardi E; Di Girolamo D; Campo G; Farrero M
    Circ Cardiovasc Interv; 2022 May; 15(5):e011656. PubMed ID: 35580200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Clinical Rejection Versus Rejection on Protocol Biopsy With Cardiac Allograft Vasculopathy in Pediatric Heart Transplant Recipients.
    Asimacopoulos EP; Garbern JC; Gauvreau K; Blume ED; Daly KP; Singh TP
    Transplantation; 2020 Jan; 104(1):e31-e37. PubMed ID: 31568274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of longitudinal myocardial deformation by 2-dimensional speckle-tracking echocardiography in heart transplant recipients: relation to coronary allograft vasculopathy.
    Clemmensen TS; Løgstrup BB; Eiskjær H; Poulsen SH
    J Heart Lung Transplant; 2015 Feb; 34(2):195-203. PubMed ID: 25108908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value of Biomarkers in Cardiac Allograft Vasculopathy following Heart Transplantation: A Literature Review.
    Habibi S; Ghaffarpasand E; Shojaei F; Alihashemi M; Kahe F; Zahedi Tajrishi F; Chi G
    Cardiology; 2020; 145(11):693-702. PubMed ID: 32892195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravascular ultrasound for cardiac allograft vasculopathy detection.
    Mendiz OA; Gamboa P; Renedo MF; Lev GA; Favaloro LE; Bertolotti AM
    Clin Transplant; 2021 Feb; 35(2):e14167. PubMed ID: 33237578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary atherosclerosis with vulnerable plaque and complicated lesions in transplant recipients: new insight into cardiac allograft vasculopathy by optical coherence tomography.
    Cassar A; Matsuo Y; Herrmann J; Li J; Lennon RJ; Gulati R; Lerman LO; Kushwaha SS; Lerman A
    Eur Heart J; 2013 Sep; 34(33):2610-7. PubMed ID: 23801824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optical Coherence Tomography for the Early Detection of Coronary Vascular Changes in Children and Adolescents After Cardiac Transplantation: Findings From the International Pediatric OCT Registry.
    McGovern E; Hosking MCK; Balbacid E; Voss C; Berger F; Schubert S; Harris KC
    JACC Cardiovasc Imaging; 2019 Dec; 12(12):2492-2501. PubMed ID: 30031706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial Perfusion Reserve and Strain-Encoded CMR for Evaluation of Cardiac Allograft Microvasculopathy.
    Erbel C; Mukhammadaminova N; Gleissner CA; Osman NF; Hofmann NP; Steuer C; Akhavanpoor M; Wangler S; Celik S; Doesch AO; Voss A; Buss SJ; Schnabel PA; Katus HA; Korosoglou G
    JACC Cardiovasc Imaging; 2016 Mar; 9(3):255-66. PubMed ID: 26965729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological and Fibrotic Mechanisms in Cardiac Allograft Vasculopathy.
    Jansen MA; Otten HG; de Weger RA; Huibers MM
    Transplantation; 2015 Dec; 99(12):2467-75. PubMed ID: 26285017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrotic Plaque and Microvascular Dysfunction Predict Early Cardiac Allograft Vasculopathy Progression After Heart Transplantation: The Early Post Transplant Cardiac Allograft Vasculopathy Study.
    Chih S; Chong AY; Džavík V; So DY; Aleksova N; Wells GA; Bernick J; Overgaard CB; Stadnick E; Mielniczuk LM; Beanlands RSB; Ross HJ
    Circ Heart Fail; 2023 Jun; 16(6):e010173. PubMed ID: 37165901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac allograft vasculopathy: a review.
    Ramzy D; Rao V; Brahm J; Miriuka S; Delgado D; Ross HJ
    Can J Surg; 2005 Aug; 48(4):319-27. PubMed ID: 16149368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.